James L Williams

Summary

Affiliation: Alaska Native Tribal Health Consortium
Country: USA

Publications

  1. ncbi Brief report on the effect of providing single versus assorted brand name condoms to hospital patients: a descriptive study
    J L Williams
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage, AK, USA
    BMC Public Health 1:5. 2001
  2. ncbi Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers
    J L Williams
    Alaska Native Medical Center, Viral Hepatitis Program, ANC HEP, 4315 Diplomacy Drive, Anchorage, AK 99508, USA
    Vaccine 19:4081-5. 2001
  3. ncbi Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992
    James L Williams
    Liver Disease and Hepatitis Program and the Community Health Aide Program, Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska 99508, USA
    Transfusion 45:1020-6. 2005
  4. ncbi Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults
    James L Williams
    Viral Hepatitis Program, Alaska Native Medical Center, ANC HEP, 4315 Diplomacy Drive, 99508, Anchorage, AK, USA
    Vaccine 21:3208-11. 2003
  5. ncbi Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992
    Henry H Cagle
    Liver Disease and Hepatitis Program, Division of Community Health, Alaska Native Tribal Health Consortium, Anchorage 99508, USA
    Arch Pediatr Adolesc Med 161:125-30. 2007
  6. ncbi Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program, Anchorage, Alaska 99508, USA
    Can J Gastroenterol 24:445-51. 2010
  7. ncbi Hepatitis B-associated vasculitis in Alaska Natives: viral genotype, clinical and serologic outcome
    Kathy J Hurlburt
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Liver Int 27:627-32. 2007
  8. ncbi Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    J Infect Dis 195:5-11. 2007
  9. ncbi Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera
    Dana L Bruden
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA
    Am J Gastroenterol 99:1517-22. 2004
  10. ncbi Prevalence of autoimmune liver disease in Alaska Natives
    Kathy J Hurlburt
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage 99508, USA
    Am J Gastroenterol 97:2402-7. 2002

Collaborators

Detail Information

Publications11

  1. ncbi Brief report on the effect of providing single versus assorted brand name condoms to hospital patients: a descriptive study
    J L Williams
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage, AK, USA
    BMC Public Health 1:5. 2001
    ..CONCLUSIONS: The provision of assorted brand name condoms, over a single brand name, can serve to increase condom acquisition. Locations of condoms and target population characteristics are related factors...
  2. ncbi Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers
    J L Williams
    Alaska Native Medical Center, Viral Hepatitis Program, ANC HEP, 4315 Diplomacy Drive, Anchorage, AK 99508, USA
    Vaccine 19:4081-5. 2001
    ..However, the absolute duration of protection from immunization is unknown. The purpose of this randomized comparison trial was to determine how previously immunized HCW respond to different booster doses of hepatitis B vaccine...
  3. ncbi Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992
    James L Williams
    Liver Disease and Hepatitis Program and the Community Health Aide Program, Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska 99508, USA
    Transfusion 45:1020-6. 2005
    ..A general transfusion lookback program was implemented to identify, counsel, and screen persons who received transfusions at the Alaska Native Medical Center between January 1980 and July 1992...
  4. ncbi Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults
    James L Williams
    Viral Hepatitis Program, Alaska Native Medical Center, ANC HEP, 4315 Diplomacy Drive, 99508, Anchorage, AK, USA
    Vaccine 21:3208-11. 2003
    ..Findings suggest a booster administered 20-31 months after the primary dose is immunogenic and GMT in persons >2 years of age were comparable to those seen in adults and children who receive hepatitis A vaccine per schedule...
  5. ncbi Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992
    Henry H Cagle
    Liver Disease and Hepatitis Program, Division of Community Health, Alaska Native Tribal Health Consortium, Anchorage 99508, USA
    Arch Pediatr Adolesc Med 161:125-30. 2007
    ..To notify persons who received a blood transfusion in a neonatal intensive care unit between January 1975 and July 1992 of their risk for hepatitis C infection and to encourage them to seek hepatitis C antibody testing...
  6. ncbi Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program, Anchorage, Alaska 99508, USA
    Can J Gastroenterol 24:445-51. 2010
    ..Various factors influence the development and rate of fibrosis progression in chronic hepatitis C virus (HCV) infection...
  7. ncbi Hepatitis B-associated vasculitis in Alaska Natives: viral genotype, clinical and serologic outcome
    Kathy J Hurlburt
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Liver Int 27:627-32. 2007
    ....
  8. ncbi Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    J Infect Dis 195:5-11. 2007
    ..The development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection has been associated with specific HBV genotypes and the presence of specific mutations...
  9. ncbi Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera
    Dana L Bruden
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA
    Am J Gastroenterol 99:1517-22. 2004
    ..CONCLUSIONS: Inaccuracies in the length of HCV could occur in outcome studies that rely on patient recall of risk-factor history. Statistical methods that incorporate the uncertainty in assigning infection date are needed...
  10. ncbi Prevalence of autoimmune liver disease in Alaska Natives
    Kathy J Hurlburt
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage 99508, USA
    Am J Gastroenterol 97:2402-7. 2002
    ..7). The prevalence of PBC was 16/100,000 (95% CI = 12.9-25.4). CONCLUSIONS: This population-based study demonstrates that the prevalence rates of AIH and PBC in Alaska natives are comparable with reported rates in other populations...
  11. ncbi Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy
    Taraz Samandari
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 120:e373-81. 2007
    ..The duration of protection provided by hepatitis B vaccination is unknown, but the presence of immune memory can be evaluated indirectly by measuring the immune response to a booster dose of vaccine...